Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | 17.9B | 17.4B | 16.3B | — |
Cost of revenue | 10.9B | 10.5B | 10.4B | — |
Gross profit | 7.0B | 6.9B | 5.9B | — |
Operating expense | ||||
Research & development | 429M | 410M | 457M | — |
Selling general and admin | 2.0B | 1.8B | 1.5B | — |
Other operating expenses | 1.4B | 1.6B | 1.4B | — |
Operating income | 2.4B | 2.4B | 1.9B | — |
Non operating interest income | ||||
Income | 42M | 106M | 47M | — |
Expense | 19M | 9M | 9M | 8M |
Other income expense | — | — | — | — |
Pretax income | 3.0B | 2.9B | 1.8B | — |
Tax provision | 755M | 1.0B | 472M | — |
Net income | 2.2B | 1.9B | 1.4B | — |
Basic EPS | — | 36.7 | — | — |
Diluted EPS | — | 36.7 | — | — |
Basic average shares | — | 49.1M | — | — |
Diluted average shares | — | 49.1M | — | — |
EBITDA | 3.1B | 2.9B | 1.9B | — |
Net income from continuing op. | — | — | — | — |
Minority interests | 2M | -50M | -27M | — |
Preferred stock dividends | 0 | 0 | 0 | — |